CRYOPORT, INC. Convertible Debt, Current
CRYOPORT, INC. (CYRX) had Convertible Debt, Current of $185.69 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2026-08-06
- 2026-06-30: Convertible Debt, Current $185.69M.
- 2026-03-31: Convertible Debt, Current $185.39M.
- 2025-12-31: Convertible Debt, Current $185.09M.
- 2025-03-31: Convertible Debt, Current $14.33M.
| Period end | Convertible Debt, Current |
|---|---|
| 2026-06-30 | $185.69M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $185.39M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $185.09M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $14.33M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $14.30M 10-K · filed 2026-03-05 |
| 2024-09-30 | $14.27M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $14.24M 10-Q · filed 2024-08-08 |
| 2015-03-31 | $0.00 10-K · filed 2015-05-19 |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-05 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-31 |
| 2014-03-31 | $1.62M 10-K · filed 2015-05-19 |
| 2013-12-31 | $390.47K 10-Q · filed 2014-02-13 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-18 |
| 2013-06-30 | $2.18M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.30M 10-K · filed 2014-06-25 |
| 2012-03-31 | $337.90K 10-K · filed 2013-06-25 |
| 2011-12-31 | $795.04K 10-Q · filed 2012-02-21 |
| 2011-09-30 | $1.35M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.89M 10-Q · filed 2011-08-15 |
| 2011-03-31 | $1.98M 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |